5Gatzemeier U,Blumenschein G,Fosella F,et al.Phase Ⅱ trial of single-agent sorafenib in patients with advanced non-small cell lung carcinoma[J].J Clin Oncol,2006,24(18S):364.
6Socinski M A,Novello S,Sanchez J M,et al.Efficacy and safety of sunitinib in previously treated,advanced non-small cell lung cancer(NSCLC)[J].J Clin Oncol,2006,24(18S):364.
7Schiller J H,Harrington D,belani C P,et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
8Kerbel R S.Antiangiogenic Drugs and Current Strategies for the Treatment of Lung Cancer[J].Semin Oncol,2004,31(1):54-60.
9Kris M G,Herbst R S,Rischin D,et al.Objective regressions in non-small cell lung cancer patients treated in phase I trails of oral ZD 1839(Iressa),a selective tyrosine kinase inhibitor that blocks the epidermal growth factor(EGFR)[J].Lung Cancer,2000,29(Suppl 1):72.
10Kris M G,Natale R B,Herbst R S,et al.Efficacy of Gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer[J].JAMA,2003,290(16):2149-2158.
